Fonte: Il Messaggero
Hope from Pomezia (Rome)
IRBM: “if clinical trials are OK, vaccine ready in late September”
The vaccine against Coronavirus could be ready for large-scale use in late September, if the clinical trials results are good. The Italian IRBM, leader in the field of molecular biotechnology, biomedical science and organic chemistry, indicates such a timeline. Through its subsidiary Advent, IRBM is working on the vaccine candidate against Coronavirus together with the Jenner Institute of Oxford University. “We might have the first stock available by year-end”, says Pietro Di Lorenzo, CEO of Advent.
Article by Mas. Gobbi published on Il Tempo Roma – 04/05/2020